Competition Has Better Business Model Than CVS Caremark (CVS)
By Benzinga Staff
November 06, 2009 9:58 AM
November 06, 2009 9:58 AM
The WSJ reported that, when CVS Caremark Corporation (NYSE: CVS) announced that its Caremark’s pharmacy benefit management was losing big clients, $10 billion of CVS’s market value got wiped out.
Even the stocks of its rivals like Medco Health Solutions (NYSE: MHS) Express Scripts, Inc. (NASDAQ: ESRX) tumbled. Both of these are independent service providers. WSJ also reports that, in all probability, the investors may have over reacted.
WSJ feels that Medco and Express Scripts, in all probability, are actually getting the market lost by CVS. That is because, their strategy is to actively monitor patient data and suggest changes to individual drug regimens. That could actually pull down the costs and insurance providers must like that.
(c) 2011 Benzinga.com. All rights reserved. This material may not be published in its entirety or redistributed without the approval of Benzinga.
We're Loving
